netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 18 of 18


Details
UPD sitematrix Changed from 0 to
26/03/2024 14:45:02
(LoweryM )
UPD FurtherInformation Changed from
  • 15mg, 30mg & 45mg film-coated tablets
26/03/2024 14:45:02
(LoweryM )
UPD Ponatinib (Iclusig®) formatting
26/03/2024 14:45:02
(LoweryM )
LDL Link Added : MHRA Drug Safety Update (October 2018): Ponatinib (Iclusig▼): reports of posterior reversible encephalopathy syndrome : https://www.gov.uk/drug-safety-update/ponatinib-iclusig-reports-of-posterior-reversible-encephalopathy-syndrome
14/07/2023 11:21:36
(dmcdermott )
LDL Link Added : MHRA Drug Safety Update (April 2017): Ponatinib  (Iclusig▼): risk of vascular occlusive events—updated advice on possible dose reduction : https://www.gov.uk/drug-safety-update/ponatinib-iclusig-risk-of-vascular-occlusive-events-updated
14/07/2023 11:21:01
(dmcdermott )
LDL Link Added : MHRA Drug Safety Update (May 2016): BCR-ABL tyrosine kinase inhibitors: risk of hepatitis B reactivation : https://www.gov.uk/drug-safety-update/bcr-abl-tyrosine-kinase-inhibitors-risk-of-hepatitis-b-reactivation
11/07/2023 17:51:13
(dmcdermott )
LDL Link Added : MHRA Drug Safety Update (July 2020): Systemically administered VEGF pathway inhibitors: risk of aneurysm and artery dissection : https://www.gov.uk/drug-safety-update/systemically-administered-vegf-pathway-inhibitors-risk-of-aneurysm-and-arte
11/07/2023 17:23:22
(dmcdermott )
UPD sitematrix Changed from 0 to
11/07/2023 17:22:54
(dmcdermott )
UPD FurtherInformation Changed from
11/07/2023 17:22:54
(dmcdermott )
UPD Ponatinib (Iclusig®) =
11/07/2023 17:22:54
(dmcdermott )
UPD sitematrix Changed from 0 to
17/12/2021 11:45:28
(LoweryM )
UPD FurtherInformation Changed from
17/12/2021 11:45:28
(LoweryM )
UPD Ponatinib (Iclusig®) formatting
17/12/2021 11:45:28
(LoweryM )
UPD Ponatinib (Iclusig®) UPDATED
09/05/2018 11:12:35
(LoweryM )
UPD Published from Draft Mode
27/10/2017 15:17:20
(DavidS )
LDL Link Added : NICE TA451 Ponatinib for treating chronic myeloid leukaemia and acute lymphoblastic leukaemia : https://www.nice.org.uk/guidance/ta451
26/10/2017 16:17:00
(DavidS )
UPD Ponatinib (Iclusig®) NICE TA451
26/10/2017 16:16:23
(DavidS )
UPD Status Changed to | Hidden | Published
22/03/2017 15:10:44
(DavidS )

 

 
netFormulary